SZSE:300452 (China)
Â
Class A
Â¥
12.72
(+1.52%)
Apr 25
Business Description
Anhui Sunhere Pharmaceutical Excipients Co Ltd
ISIN : CNE100001ZH5
Share Class Description:
SZSE:300452: Class ACompare
Compare
Traded in other countries / regions
300452.China IPO Date
2015-05-15Description
Anhui Sunhere Pharmaceutical Excipients Co Ltd is engaged in the research, development, production, and sales of pharmaceutical excipients. It is a pharmaceutical excipient manufacturer and is the oral product's producer in China. The company's products are cover fillers, adhesives, disintegrants, lubricants, coating materials and other common oral solid preparations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.08 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | 1.67 | |||||
| Interest Coverage | 59.26 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.84 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.9 | |||||
| 3-Year EBITDA Growth Rate | 12.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.8 | |||||
| 3-Year FCF Growth Rate | 49.6 | |||||
| 3-Year Book Growth Rate | 11.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.21 | |||||
| 9-Day RSI | 48.45 | |||||
| 14-Day RSI | 48.46 | |||||
| 6-1 Month Momentum % | -11.63 | |||||
| 12-1 Month Momentum % | -29.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.47 | |||||
| Quick Ratio | 3.18 | |||||
| Cash Ratio | 2.41 | |||||
| Days Inventory | 52.49 | |||||
| Days Sales Outstanding | 38.75 | |||||
| Days Payable | 130.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| 3-Year Dividend Growth Rate | 36.5 | |||||
| Forward Dividend Yield % | 2 | |||||
| 5-Year Yield-on-Cost % | 9.56 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -2.74 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.38 | |||||
| Operating Margin % | 20.12 | |||||
| Net Margin % | 19.47 | |||||
| FCF Margin % | 4.54 | |||||
| ROE % | 20.98 | |||||
| ROA % | 12.49 | |||||
| ROIC % | 24.75 | |||||
| ROC (Joel Greenblatt) % | 40.07 | |||||
| ROCE % | 17.86 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.43 | |||||
| PE Ratio without NRI | 18.96 | |||||
| Shiller PE Ratio | 27.06 | |||||
| Price-to-Owner-Earnings | 26.15 | |||||
| PEG Ratio | 1.06 | |||||
| PS Ratio | 3.63 | |||||
| PB Ratio | 3.58 | |||||
| Price-to-Tangible-Book | 4.03 | |||||
| Price-to-Free-Cash-Flow | 75 | |||||
| Price-to-Operating-Cash-Flow | 23.47 | |||||
| EV-to-EBIT | 14.88 | |||||
| EV-to-EBITDA | 14.88 | |||||
| EV-to-Revenue | 3.2 | |||||
| EV-to-FCF | 69.38 | |||||
| Price-to-Projected-FCF | 2.39 | |||||
| Price-to-DCF (Earnings Based) | 1.18 | |||||
| Price-to-DCF (FCF Based) | 2.4 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.45 | |||||
| Price-to-Graham-Number | 1.84 | |||||
| Price-to-Net-Current-Asset-Value | 12.98 | |||||
| Earnings Yield (Greenblatt) % | 6.72 | |||||
| FCF Yield % | 1.25 | |||||
| Forward Rate of Return (Yacktman) % | 14.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anhui Sunhere Pharmaceutical Excipients Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 819.69 | ||
| EPS (TTM) (Â¥) | 0.69 | ||
| Beta | 0.81 | ||
| Volatility % | 29.67 | ||
| 14-Day RSI | 48.46 | ||
| 14-Day ATR (Â¥) | 0.342286 | ||
| 20-Day SMA (Â¥) | 12.615 | ||
| 12-1 Month Momentum % | -29.49 | ||
| 52-Week Range (Â¥) | 9.92 - 19.47 | ||
| Shares Outstanding (Mil) | 234.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anhui Sunhere Pharmaceutical Excipients Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anhui Sunhere Pharmaceutical Excipients Co Ltd Frequently Asked Questions
What is Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452)'s stock price today?
The current price of SZSE:300452 is ¥12.72. The 52 week high of SZSE:300452 is ¥19.47 and 52 week low is ¥9.92.
When is next earnings date of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452)?
The next earnings date of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) is .
Does Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) pay dividends? If so, how much?
The Dividend Yield %  of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) is 2% (As of Today), Highest Dividend Payout Ratio of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) was 0.59. The lowest was 0.21. And the median was 0.37. The  Forward Dividend Yield % of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) is 2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers